Greg A. Somerville
Affiliations: | Integrative Biomedical Sciences | The University of Nebraska - Lincoln, Lincoln, NE |
Area:
Microbiology Biology, BiochemistryGoogle:
"Greg Somerville"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kebriaei R, Bayer AS, Lapitan CK, et al. (2022) Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium : Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model. Antibiotics (Basel, Switzerland). 11 |
| Somerville GA, Parrett AA, Reed JM, et al. (2022) Human Serum Alters the Metabolism and Antibiotic Susceptibility of . Journal of Proteome Research |
| Pätzold L, Brausch AC, Bielefeld EL, et al. (2021) Impact of the Histidine-Containing Phosphocarrier Protein HPr on Carbon Metabolism and Virulence in . Microorganisms. 9 |
| Parrett A, Reed JM, Gardner SG, et al. (2020) Metabolic changes associated with adaptive resistance to daptomycin in Streptococcus mitis-oralis. Bmc Microbiology. 20: 162 |
| Gunaratnam G, Tuchscherr L, Elhawy MI, et al. (2019) ClpC affects the intracellular survival capacity of Staphylococcus aureus in non-professional phagocytic cells. Scientific Reports. 9: 16267 |
| Reed JM, Gardner SG, Mishra NN, et al. (2019) Metabolic interventions for the prevention and treatment of daptomycin non-susceptibility in Staphylococcus aureus. The Journal of Antimicrobial Chemotherapy |
| Somerville G, Powers R, Rose, et al. (2019) 614. Metabolic Interventions for the Resensitization of Daptomycin-Resistant (DAP-R) Streptococcus mitis-oralis Strains to DAP In vitro and Ex Vivo in a Simulated Model of Experimental Endocarditis (IE) Open Forum Infectious Diseases. 6: S286-S286 |
| Reed JM, Olson S, Brees DF, et al. (2018) Coordinated regulation of transcription by CcpA and the Staphylococcus aureus two-component system HptRS. Plos One. 13: e0207161 |
| Gardner SG, Marshall DD, Daum RS, et al. (2017) Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility. Antimicrobial Agents and Chemotherapy |
| Stevens E, Laabei M, Gardner S, et al. (2017) Cytolytic toxin production by Staphylococcus aureus is dependent upon the activity of the protoheme IX farnesyltransferase. Scientific Reports. 7: 13744 |